These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 19382398)

  • 1. Dexrazoxane: new indication. Anthracycline extravasation: continue using dimethyl sulfoxide.
    Prescrire Int; 2009 Feb; 18(99):6-8. PubMed ID: 19382398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone.
    Langer SW; Thougaard AV; Sehested M; Jensen PB
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):125-8. PubMed ID: 16001176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy.
    Kane RC; McGuinn WD; Dagher R; Justice R; Pazdur R
    Oncologist; 2008 Apr; 13(4):445-50. PubMed ID: 18448560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dexrazoxane in anthracycline induced cardiotoxicity and extravasation].
    Goey AK; Schellens JH; Beijnen JH; Huitema AD
    Ned Tijdschr Geneeskd; 2010; 154():A1155. PubMed ID: 20619024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of dexrazoxane for the prevention of anthracycline extravasation injury.
    Hasinoff BB
    Expert Opin Investig Drugs; 2008 Feb; 17(2):217-23. PubMed ID: 18230055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful experience utilizing dexrazoxane treatment for an anthracycline extravasation.
    Tyson AM; Gay WE
    Ann Pharmacother; 2010 May; 44(5):922-5. PubMed ID: 20371757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of anthracycline extravasation injuries.
    Reeves D
    Ann Pharmacother; 2007 Jul; 41(7):1238-42. PubMed ID: 17550954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of anthracycline extravasation with dexrazoxane -- clinical experience.
    Frost A; Gmehling D; Azemar M; Unger C; Mross K
    Onkologie; 2006 Jul; 29(7):314-8. PubMed ID: 16874015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful dexrazoxane treatment of a potentially severe extravasation of concentrated doxorubicin.
    Conde-Estévez D; Saumell S; Salar A; Mateu-de Antonio J
    Anticancer Drugs; 2010 Sep; 21(8):790-4. PubMed ID: 20671512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of dexrazoxane for the reduction of anthracycline-induced cardiotoxicity.
    Jones RL
    Expert Rev Cardiovasc Ther; 2008 Nov; 6(10):1311-7. PubMed ID: 19018683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexrazoxane for anthracycline extravasation.
    Langer SW
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1081-8. PubMed ID: 18028016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical nurse specialist and evidence-based practice: managing anthracycline extravasation.
    Hooke MC
    J Pediatr Oncol Nurs; 2005; 22(5):261-4. PubMed ID: 16079361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies.
    Mouridsen HT; Langer SW; Buter J; Eidtmann H; Rosti G; de Wit M; Knoblauch P; Rasmussen A; Dahlstrøm K; Jensen PB; Giaccone G
    Ann Oncol; 2007 Mar; 18(3):546-50. PubMed ID: 17185744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Other uses of dexrazoxane: Savene, the first proven antidote against anthracycline extravasation injuries.
    Langer SW; Jensen PB; Sehested M
    Cardiovasc Toxicol; 2007; 7(2):151-3. PubMed ID: 17652821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Totect: a new agent for treating anthracycline extravasation.
    Schulmeister L
    Clin J Oncol Nurs; 2007 Jun; 11(3):387-95. PubMed ID: 17623623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexrazoxane efficacy for anthracycline extravasation: use in UK clinical practice.
    Muthuramalingam S; Gale J; Bradbury J
    Int J Clin Pract; 2013 Mar; 67(3):244-9. PubMed ID: 23409691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexrazoxane: a second look. Prevention of anthracycline cardiotoxicity: useful for some patients.
    Prescrire Int; 2008 Oct; 17(97):195. PubMed ID: 19534047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A murine experimental anthracycline extravasation model: pathology and study of the involvement of topoisomerase II alpha and iron in the mechanism of tissue damage.
    Thougaard AV; Langer SW; Hainau B; Grauslund M; Juhl BR; Jensen PB; Sehested M
    Toxicology; 2010 Feb; 269(1):67-72. PubMed ID: 20079798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexrazoxane in anthracycline extravasation.
    Langer SW; Sehested M; Jensen PB; Buter J; Giaccone G
    J Clin Oncol; 2000 Aug; 18(16):3064. PubMed ID: 10944144
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of anthracycline extravasation with dexrazoxane.
    Langer SW; Sehested M; Jensen PB
    Clin Cancer Res; 2000 Sep; 6(9):3680-6. PubMed ID: 10999761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.